Kanabo Group Plc (LSE:KNB), a medical cannabis and R&D Company that focuses on the distribution of cannabis-derived products for medical
THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates
Kanabo, one of Europe’s fastest-growing medical cannabis R&D companies that focuses on the distribution of cannabis-derived products for medical patients,
KANABO’s proposed share-based purchase of high-profile medical cannabis business Materia Ventures is the ‘perfect match’, says Avihu Tamir, its founder
PROPOSALS to set a minimum valuation level for companies looking to list on the London Stock Exchange could limit the
THE London Stock Exchange will accept the first cannabis company in its 320-year history next month – marking a significant
THE UK can ride the global green wave to boost the domestic economy in the post-Covid, post-Brexit world, says a
UK company Spinnaker Opportunities hopes to become the first cannabis company to list on the London Stock Exchange – within a
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
